Sensitive

Breast-ovarian cancer, familial, susceptibility to, 2

BRCA2 · rs80358920

Stands on its own. Nothing else here links to this position yet — but the page above is the point: what the research found, what each genotype means, and where it came from, in language you can read. Links to conditions, drugs and the senses appear automatically if we write them.

Strength of the evidence

4 / 4

ClinVar classifies it as disease-causing (or likely), reviewed at 3 of 4 stars.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10⁻⁵⁰. 2: ClinVar from one lab (1 star), or p ≤ 10⁻²⁰. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10⁻⁸). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What ClinVar records

Classification Pathogenic for Breast-ovarian cancer, familial, susceptibility to, 2, Hereditary breast ovarian cancer syndrome, Breast neoplasm, Hereditary cancer-predisposing syndrome, Ovarian neoplasm and 5 more; reviewed by expert panel (3 of 4 stars, 42 submitters), last evaluated 2016-04-22. ClinVar record 38076 NM_000059.4(BRCA2):c.6952C>T (p.Arg2318Ter)

Classification Uncertain significance for Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome, Malignant tumor of esophagus, Hereditary nonpolyposis colorectal carcinoma, Breast and/or ovarian cancer and 1 more; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 7 submitters), last evaluated 2025-07-30. ClinVar record 409599 NM_000059.4(BRCA2):c.6952C>G (p.Arg2318Gly)

Classification Likely benign for Hereditary cancer-predisposing syndrome; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 2 submitters), last evaluated 2022-01-25. ClinVar record 1172850 NM_000059.4(BRCA2):c.6952C>A (p.Arg2318=)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-09 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

CT

Japanese ToMMo

C 100.0% · T 0.0%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. No Korean figure for this position yet.

What each result means

C/C No copy of the version ClinVar lists as disease-causing for Breast-ovarian cancer, familial, susceptibility to, 2. This is the usual result. (ClinVar VCV000038076, reviewed by expert panel)

C/T One copy of the version ClinVar lists as disease-causing for Breast-ovarian cancer, familial, susceptibility to, 2. Some conditions need only one copy; for others, one copy makes a person a carrier who is usually healthy but can pass it on. A genetic counsellor can say which applies. (ClinVar VCV000038076, reviewed by expert panel)

T/T Two copies of the version ClinVar lists as disease-causing for Breast-ovarian cancer, familial, susceptibility to, 2. A result like this should be confirmed by a medical genetic test and talked through with a doctor; consumer DNA files can misread rare variants. (ClinVar VCV000038076, reviewed by expert panel)

Source: ClinVar VCV000038076, reviewed by expert panel

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Breast-ovarian cancer, familial, susceptibility to, 2 (rs80358920). MyGeneLog™. https://www.mygenelog.com/variants/rs80358920

← See all variants